Drug-induced rhinitis as a complication of using mucosal decongestants

Rhinitis medicamentosa is induced by the overuse of topical nasal decongestants. It is characterized by chronic nasal obstruction, not related to allergy or common cold. This problem often affects young and middle-aged patients who, in order to reduce nasal congestion, exudation and swelling of the nasal mucosa, use drugs that only initially relieve the patient's symptoms. Rhinitis medicamentosa is associated with the risk of many complications, including the development of nasal polyps, otitis and sinusitis. The basis of treatment is discontinuation of decongestants and the use of nasal corticosteroid. In situations where conservative treatment is not sufficient, surgical methods can also be used. It is complicated to cure and the therapy is often long-lasting. Therefore, it seems much easier to prevent the development of rhinitis medicamentosa by avoiding this type of drugs or using nasal decongestant only for short periods and in correct doses.

Authors

Institutions

Publication Details

Journal
Journal of Education Health and Sport
Published
2025-05-23
DOI
https://doi.org/10.12775/jehs.2025.80.59787
Citations
1
Primary Topic
Allergic Rhinitis and Sensitization
Type
article
Field-Weighted Citation Impact
1.62
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-induced rhinitis as a complication of using mucosal decongestants

A. F. Ratajczak, Olga Snoch, Zuzanna Kalinowska, Weronika Matera
1 citations
Journal of Education Health and Sport
Allergic Rhinitis and Sensitization
1.62
article

Drug-induced rhinitis as a complication of using mucosal decongestants

A. F. Ratajczak, Olga Snoch, Zuzanna Kalinowska, Weronika Matera
article en
1 citations

Abstract

Rhinitis medicamentosa is induced by the overuse of topical nasal decongestants. It is characterized by chronic nasal obstruction, not related to allergy or common cold. This problem often affects young and middle-aged patients who, in order to reduce nasal congestion, exudation and swelling of the nasal mucosa, use drugs that only initially relieve the patient's symptoms. Rhinitis medicamentosa is associated with the risk of many complications, including the development of nasal polyps, otitis and sinusitis. The basis of treatment is discontinuation of decongestants and the use of nasal corticosteroid. In situations where conservative treatment is not sufficient, surgical methods can also be used. It is complicated to cure and the therapy is often long-lasting. Therefore, it seems much easier to prevent the development of rhinitis medicamentosa by avoiding this type of drugs or using nasal decongestant only for short periods and in correct doses.

Journal of Education Health and SportVol. 80
Wroclaw Medical University (PL)
Openalex Percentile: Top 19%
Allergic Rhinitis and Sensitization
1.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.